Current opinion in oncology
-
This review highlights how progress has been made in treating limited small cell lung cancer and outlines current challenges to overcome for improved cure rates. ⋯ Concurrent chemoradiotherapy is associated with a one in four chance of cure. Two ongoing phase III trials have been designed to address the optimal radiotherapy regimen to combine with cisplatin and etoposide. Close collaboration between radiation and medical oncologists is needed to make further progress and to improve patient access to curative intent concurrent chemoradiotherapy regimens.